In an ApoE−/− high-fat diet murine model of atherosclerosis, delivery of a small molecule CCR2 antagonist showed significant decrease in plaque size and lesional macrophage numbers only in mice treated at ZT17 but not when the same antagonist was applied at ZT5. The gene discussed is APOE; the disease is atherosclerosis.